Brief: Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company's Vision AI Platform
25/03/2025 12:23
March 25 (Reuters) - Avant Technologies Inc AVAI.PK: AVANT TECHNOLOGIES AND AINNOVA BEGIN DESIGNING CLINICAL TRIAL PROTOCOL FOR COMPANY'S VISION AI PLATFORM Source text: ID:nPnzh1nva Further company coverage: AVAI.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avai Bio
See all newsBrief: Avai Bio, Ainnova Tech terminate JV, license agreement on May 7, 2026 - SEC Filing
Brief: Avaí Bio And Austrianova Begin Production Of Master Cell Bank For Klotho Anti-Aging Therapy Under Gmp Standards
Brief: Avant Technologies And JV Partner, Ainnova, Prepare For Key FDA Milestone With Next Week's Pre-Submission Meeting
Brief: Avant Technologies Signs Letter Of Intent For A Business Combination
Brief: Avant Technologies And Ainnova Tech Begin Acquisition Talks